| Patents for A61P 25 - Drugs for disorders of the nervous system (183,225) |
|---|
| 01/09/2003 | CA2450354A1 Enhanced systemic absorption of intradermally delivered substances |
| 01/09/2003 | CA2424645A1 New use of dipeptidyl peptidase iv inhibitors |
| 01/09/2003 | CA2418543A1 New dipeptidyl peptidase iv inhibitors and their uses as anti-cancer agents |
| 01/08/2003 | EP1273659A1 Novel g protein-coupled receptor protein and dna thereof |
| 01/08/2003 | EP1273657A1 Novel protein, process for producing the same and use thereof |
| 01/08/2003 | EP1273582A1 Heterocyclo-alkylsulfonyl pyrazoles as anti-inflammatory/analgesic agents |
| 01/08/2003 | EP1273580A1 Sulfonyl heteroaryl triazoles as anti-inflammatory and analgesic agents |
| 01/08/2003 | EP1273576A1 Sulfonyl aryl triazoles as anti-inflammatory/analgesic agents |
| 01/08/2003 | EP1273300A2 A stable external preparation containing aspirin |
| 01/08/2003 | EP1273289A1 Pharmaceutical compositions containing ascomycin derivatives |
| 01/08/2003 | EP1273288A1 Pharmaceutical compositions containing rapamycin derivatives |
| 01/08/2003 | EP1272853A2 Methods for identifying and using amyloid-inhibitory compounds |
| 01/08/2003 | EP1272852A1 Tpst-assay for diagnosis of autism and related disorders |
| 01/08/2003 | EP1272635A1 Cryptic-like secreted protein |
| 01/08/2003 | EP1272614A1 Differentiation of bone marrow cells into neuronal cells and uses therefor |
| 01/08/2003 | EP1272518A2 Cd20/ige-receptor like molecules and uses thereof |
| 01/08/2003 | EP1272517A2 Multiprotein-complexes comprising a nmda receptor and uses thereof |
| 01/08/2003 | EP1272515A2 Immunoregulator |
| 01/08/2003 | EP1272514A1 Dna encoding human vanilloid receptor vr3 |
| 01/08/2003 | EP1272513A2 Neurogenic compositions and methods |
| 01/08/2003 | EP1272511A2 Molecules associated with human reproduction |
| 01/08/2003 | EP1272509A2 Prion-binding peptidic ligands and methods of using same |
| 01/08/2003 | EP1272505A1 8beta-substituted-11beta-pentyl- and 11beta-hexyl-estra-1,3,5(10)-triene derivatives |
| 01/08/2003 | EP1272504A1 8beta-hydrocarbyl-substituted estratrienes for use as selective estrogens |
| 01/08/2003 | EP1272499A1 Pharmaceutical compositions containing oligosaccharides and preparation thereof |
| 01/08/2003 | EP1272489A1 Process for preparing crystalline form i of cabergoline |
| 01/08/2003 | EP1272488A2 Tri-aryl-substituted-ethane pde4 inhibitors |
| 01/08/2003 | EP1272484A2 Benzoamide piperidine compounds as substance p antagonists |
| 01/08/2003 | EP1272481A1 4-fluoroalkyl-2h-benzopyrans with anti-estrogenic activity |
| 01/08/2003 | EP1272470A1 Amorphous torasemide modification |
| 01/08/2003 | EP1272469A1 Naphthalene derivatives and their pharmaceutical use |
| 01/08/2003 | EP1272468A1 Indolin-2-one derivatives, preparation and their use as ocytocin receptor ligands |
| 01/08/2003 | EP1272455A1 Halogenated 2-amino-4, 5 heptenoic acid derivatives useful as nitric oxide synthase inhibitors |
| 01/08/2003 | EP1272218A2 A pharmaceutical composition for treatment of acute, chronic pain and/or neuropathic pain and migraines |
| 01/08/2003 | EP1272209A1 Use of crf receptor agonists for the treatment or prophylaxis of diseases, for example neurodegenerative diseases |
| 01/08/2003 | EP1272204A2 Soft tissue and bone augmentation and bulking utilizing muscle-derived progenitor cells, compositions and treatments thereof |
| 01/08/2003 | EP1272201A2 Use of compatible solutes as substances having free radical scavenging properties |
| 01/08/2003 | EP1272192A2 A use of galantamine for the treatment of neuropsychiatric behaviour associated with alzheimer's disease |
| 01/08/2003 | EP1272191A2 An efficacious dosage regimen of galantamine that reduces side effects |
| 01/08/2003 | EP1272190A2 A use of galantamine for the treatment of alzheimer's disease; targeting the underlying cause of the disease |
| 01/08/2003 | EP1272187A1 Use of dopamine-d3 receptor ligands for the treatment of diseases of the central nervous system |
| 01/08/2003 | EP1272182A2 Use of sabcomeline in the treatment of anxiety |
| 01/08/2003 | EP1272177A1 Method and formulation for treating resistance to antihypertensives and related conditions |
| 01/08/2003 | EP1272175A2 Il-8 receptor antagonists |
| 01/08/2003 | EP1272172A2 Use of breakers of advanced glycation endproducts for treating deleterious effects of aging and debilitating diseases |
| 01/08/2003 | EP1272169A2 Use of 13-hode as a regulator of vascular biocompatibility and an inhibitor of cell hyperplasia |
| 01/08/2003 | EP1272168A2 Small organic molecule regulators of cell proliferation |
| 01/08/2003 | EP1272167A1 Hydrophilic/lipophilic polymeric matrix dosage formulation |
| 01/08/2003 | EP1272058A2 Infant formulas containing long-chain polyunsaturated fatty acids and uses thereof |
| 01/08/2003 | EP1123284B1 Method for the preparation of citalopram |
| 01/08/2003 | EP1121356B1 3-tetrahydropyridin-4-yl indoles for treatment of psychotic disorders |
| 01/08/2003 | EP1119355B1 Naphthalenecarboxamides as tachykinin receptor antagonists |
| 01/08/2003 | EP1087973B1 Imidazotriazolopyrimidines used as a drug having an adenosine antagonist activity |
| 01/08/2003 | EP0934286B1 3-alkoxyisoxazol-4-yl-substituted 2-amino carboxylic acid compounds |
| 01/08/2003 | EP0728194B1 In situ modification and manipulation of stem cells of the central nervous system |
| 01/08/2003 | CN1390232A Human beta-secretase enzyme, inhibitor, and its composition and use |
| 01/08/2003 | CN1390231A Metal-binding compounds and uses thereof |
| 01/08/2003 | CN1390222A Imidazole compounds used as phosphodiesterase VII inhibitors |
| 01/08/2003 | CN1390221A Spiro (2H-1-benzopyran-2,4'-piperididine) derivates as glycine transport inhibitors |
| 01/08/2003 | CN1390219A Pyrazolopyrimidines as therapeutic agents |
| 01/08/2003 | CN1390217A Bicyclic and tricyclic heteroaromatic compounds |
| 01/08/2003 | CN1390216A Polymorphsof crystalline (2-benzhycrryl-1-azabicyclo [2,2,2] oct-3-YC)-(5-isopropyl-2-methoxybenzyl)-ammoniumchloride as NK-1 receptor antagonists |
| 01/08/2003 | CN1390214A New phenylpiperazines |
| 01/08/2003 | CN1390205A Novel compound |
| 01/08/2003 | CN1390137A A Blocking monoclonal antibody to VLA-1 and its use for the treatment of inflammatory disorders |
| 01/08/2003 | CN1390128A Use of adatanserin for treating neurogenerative disorders |
| 01/08/2003 | CN1390121A Morphine sulphate microgranules, method for preparing same and compositions containing same |
| 01/08/2003 | CN1390118A Dextrose and insulin fluid formulation for intravenous infusion |
| 01/08/2003 | CN1389264A Medicine for abstinence of drugs and its prepn. |
| 01/08/2003 | CN1389251A Composite medicine for treating epilepsy |
| 01/08/2003 | CN1389245A Composite Chinese medicine for treating atrophy and flaccid paralysis of legs |
| 01/08/2003 | CN1389217A Wind and cold dispelling Chinese medicine for treating Bell's palsy and its prepn. |
| 01/08/2003 | CN1389208A Orally taken pulsed releasing system of phenyl diazepine medicine and its prepn. |
| 01/08/2003 | CN1389201A New use of coenzyme Q10 |
| 01/08/2003 | CN1098266C Fused pyrrolo (2,3-c) carbazole-6-one which potentiate activity of gamma interferon |
| 01/08/2003 | CN1098263C Pyridin-2-yl-methylaminederivatives, method of preparing and application as medicine |
| 01/08/2003 | CN1098256C Substd. benzenesulfonamide derivatives as prodrugs of COX-2 inhibitors |
| 01/08/2003 | CN1098255C Novel substituted piperazine derivatives having tachyknin receptor antagonists activity |
| 01/08/2003 | CN1098090C Drug-dropping capsule and its preparing process |
| 01/07/2003 | US6503935 Imidazoles and related compounds as α1A agonists |
| 01/07/2003 | US6503931 Use of 4-amino pyridine for treatment of peripheral neuropathies |
| 01/07/2003 | US6503927 Amorphous paroxetine composition |
| 01/07/2003 | US6503925 Treating anxiety, anesthesia, and epilepsy |
| 01/07/2003 | US6503920 Adminstering to treat progressive supranuclear palsy, Parkinson*s disease, and central nervous system disorders |
| 01/07/2003 | US6503914 Thienopyrimidine-based inhibitors of the Src family |
| 01/07/2003 | US6503909 Administering as antiepileptic or anticonvulsant agents; treating central nervous system disorders with dihydrofolate reductase inhibitors; side effect reduction |
| 01/07/2003 | US6503908 Pharmaceutically active compounds |
| 01/07/2003 | US6503905 3,3-biarylpiperidine and 2,2-biarylmorpholine derivatives |
| 01/07/2003 | US6503901 Amino lactam sulfonamides as inhibitors of Aβ protein production |
| 01/07/2003 | US6503900 [1,4]diazepino [6,7,1-jk ]carbazoles and derivatives |
| 01/07/2003 | US6503899 Azepino[4,5-b]pyrano[3,2-e]indoles |
| 01/07/2003 | US6503888 AAV-mediated delivery of DNA to cells of the nervous system |
| 01/07/2003 | US6503737 Isolated nucleic acids relating to the fkbA gene within the FK-520 polyketide synthase gene cluster |
| 01/07/2003 | US6503728 A nucleic acid comprising a nucleic acid sequence encoding pantropic hNT3 or hNGF having an alanine residue substituted at a position corresponding to D15 in hNT3 or D16 in hNGF, wherein the alanine substitution imparts trkB-binding such |
| 01/07/2003 | US6503713 Methods for identifying RNA binding compounds |
| 01/07/2003 | US6503543 Tryptophan source from plants and uses therefor |
| 01/07/2003 | US6502789 Flexible kite |
| 01/07/2003 | CA2214845C Film-forming pharmaceutical composition for transdermic delivery |
| 01/07/2003 | CA2124784C Pentanoic acid derivatives |
| 01/07/2003 | CA2075684C 1-acylpiperidine compounds |